Sign inJoin waitlistJoin the waitlist

Wilbur Chen

Chief of the Division of Geographic Medicine · Univ of Maryland Sch of Med

Credentials: · · · · ·

History

Division of Geographic Medicine · Univ of Maryland Sch of Med
Present
Univ of Maryland Sch of Med
Present
Univ of Maryland Sch of Med · University of Maryland Capital Region Health
Present

Infectious Disease
University of Maryland Medical Center
2002–2004
Internal Medicine
Johns Hopkins University School of Medicine
1999–2002
Howard University College of Medicine
1995–1999

Research

Norovirus vaccine against experimental human Norwalk Virus illness
New England Journal of Medicine · 2011 · 373 citations
The TLR4 antagonist Eritoran protects mice from lethal influenza infection
Nature · 2013 · 372 citations
Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised…
The Lancet Infectious Diseases · 2016 · 205 citations

Myron Levine
20 papers
Karen Kotloff
15 papers
Patricia Winokur
15 papers
Sharon Frey
15 papers
Alan Cross
13 papers
RA
Robert Atmar
13 papers
Justin Ortiz
11 papers
Kathleen Neuzil
11 papers
Kathryn Edwards
11 papers
LJ
Lisa Jackson
11 papers
Clarence Creech
9 papers
Rebecca Brady
9 papers

Grants

Mechanisms of Mucosal and Systemic Immunity to Vaccination and Infection with Enteric Pathogens in Children and Adults
National Institute of Allergy and Infectious Diseases · U19
Project lead · $622K · University of Maryland Baltimore
2024–2029
Advanced Development of a Combined Shigella-ETEC Vaccine
National Institute of Allergy and Infectious Diseases · R01
PI · $4.4M · University of Maryland Baltimore
2023–2028
Planning Grant to Evaluate the Use of Pentavalent Meningococcal Vaccine in Pregnant Women in Sub-Saharan Africa
National Institute of Allergy and Infectious Diseases · R34
Contact PI · $233.3K · University of Maryland Baltimore
2026–2027
Evaluating Modes of Influenza Transmission (EMIT-2) Using Innovative Technologies and Designs in Controlled Environments
National Institute of Allergy and Infectious Diseases · U19
Project lead · $5M · Univ of Maryland, College Park
2021–2027

Clinical trials

Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis
Principal investigator · Active not recruiting · Phase 1, Phase 2
Intralytix, Inc.
2023–2025
Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122
Principal investigator · Completed · Phase 1
University of Maryland, Baltimore
2022–2024
Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults
Principal investigator · Withdrawn · Phase 2
PATH
2017–2019
Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults
Principal investigator · Completed · Phase 1
PATH
2016–2017